Exploring Biomarkers for Dementia Risk in Parkinson's Disease

This chapter explores the significance of biomarkers in assessing dementia risk among Parkinson's disease patients. It highlights ongoing research into synuclein seed amplification assays and MRI findings, emphasizing the necessity for further studies to clarify their relationship with cognitive decline.